Melissa A Geller

8PUBLICATIONS
86CO-AUTHORS
Tumour immunologyPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 21, 2025
TGF-βRII/IL-15 immunotherapeutic complex targets exhausted CD8+ T-cell subsets in lymph nodes and tumors.

Varghese K George, Hing C Wong, Martin Felices

|Nov 21, 2025
Assessment of Active Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Infections and Patient Reported Fatigue in Ovarian Cancer Survivors.

Xuan Li, Katherine Brown, Kate Honeyfield

|Jun 26, 2025
HSD3B1 (c.1100C) Genotype Is Associated with Distinct Tumoral and Clinical Outcomes in Breast and Endometrial Cancers.

Nikitha Vobugari, Allison Makovec, Samuel Kellen

|Jun 09, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer.

Mary L Disis, Sarah F Adams, Jyoti Bajpai

|Feb 22, 2023
Reverse Translation Identifies the Synergistic Role of Immune Checkpoint Blockade and IL15 to Enhance Immunotherapy of Ovarian Cancer.

Martin Felices, Erin Wesley, Laura E Bendzick

|Mar 16, 2022
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.

Kunle Odunsi, Feng Qian, Amit A Lugade

Pageof 2

Frequent Collaborators

2 joint publications

Martin Felices

2 joint publications

Emese Zsiros

2 joint publications

Kunle Odunsi

1 joint publications

Joyce F Liu